Spirudio
NDC 87754-0002, Spirudio, tablet, from PROGRESYVUS TYRIMAI MB.
- Product NDC
- 87754-0002
- Status
- Listed
- Labeler
- PROGRESYVUS TYRIMAI MB
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87754-0002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAPINE S-100 IMMUNE GLOBULIN30 [hp_C]/U
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87754-0002-1 | 87754000201 | 60 U in 1 BOTTLE (87754-0002-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 87754-0002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87754-0002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87754-0002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.